Ophthalmic Research Associates — Andover, Massachusetts

Ophthalmic Research Associates is a clinical research site located in Andover, Massachusetts, United States 01810.

Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.

Ophthalmic Research Associates has participated in 8 clinical trials.

Therapeutic areas: Dry Eye Syndrome, Blepharitis, Allergic Conjunctivitis.

Sponsors: Eyegate Pharmaceuticals, Inc., Merck Sharp & Dohme LLC, ORA, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Andover

Browse all research sites in Massachusetts · View every site in Andover

• Lawrence General Hospital
• Andover Eye Associates
• Ora
• CYS-002 Investigational Site
• Andover
• 101 Andover Eye Associates
• Vanda Investigational Site
• Ora Clinical Research Center
• INSIGHT-1 Study Site #1
• Andover, MA
• ORA Clinical Research and Development

Sponsor Feasibility Report

Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ophthalmic Research Associates?

Ophthalmic Research Associates has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ophthalmic Research Associates conducted?

Ophthalmic Research Associates has 8 clinical trials on record. Their work covers Dry Eye Syndrome, Blepharitis, Allergic Conjunctivitis.

Is Ophthalmic Research Associates accredited by Crixeo Clinical Trials?

Ophthalmic Research Associates has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ophthalmic Research Associates?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.